You don't 'own' your own genes: Researchers raise alarm about loss of individual 'genomic liberty' due to gene patents
Humans don't "own" their own genes, the cellular chemicals that define who they are and what diseases they might be at risk for. Through more than 40,000 patents on DNA molecules, companies have essentially ...
Genetics
Mar 26, 2013 |
4.8 / 5 (20) |
17
|
High court weighs drug companies' generics policy
(AP)—The Supreme Court is struggling with whether it should stop pharmaceutical corporations from paying generic drug competitors to delay releasing their cheaper versions of brand-name drugs.
Medications
Mar 25, 2013 |
not rated yet |
0
AstraZeneca settles legal dispute with Watson (Update)
(AP)—Anglo-Swedish pharmaceutical company AstraZeneca has settled a patent dispute with Watson Laboratories, Inc., removing a threat against its top-selling cholesterol-control drug, Crestor.
Medications
Mar 25, 2013 |
not rated yet |
0
AstraZeneca to cut 2,300 jobs in business overhaul
(AP)—Struggling drug company AstraZeneca outlined a major restructuring of its business on Thursday, including some 2,300 job cuts worldwide as it overhauls its research operations.
Medications
Mar 21, 2013 |
not rated yet |
0
White blood cells found to play key role in controlling red blood cell levels
Researchers at Albert Einstein College of Medicine of Yeshiva University and the Icahn School of Medicine at Mount Sinai have found that macrophages – white blood cells that play a key role in the immune response – also ...
Medical research
Mar 17, 2013 |
4.7 / 5 (3) |
1
|
Study shows how vitamin E can help prevent cancer
Researchers have identified an elusive anti-cancer property of vitamin E that has long been presumed to exist, but difficult to find.
Cancer
Mar 14, 2013 |
5 / 5 (1) |
0
|
Computer models predict how patients will respond to HIV drugs
Results of a study published online in the Journal of Antimicrobial Chemotherapy today (Thursday), demonstrate that computer models can predict how HIV patients whose drug therapy is failing will respond to a new treatment. Crucia ...
HIV & AIDS
Mar 13, 2013 |
not rated yet |
0
Big Pharma battle threatens to delay Pacific trade pact
A US-led Pacific free trade pact faces further delays as a row between Big Pharma and activists supporting access to generic drugs erupts ahead of an October deadline, officials say.
Medications
Mar 10, 2013 |
not rated yet |
1
Pfizer painkiller gets longer patent protection (Update)
Drugmaker Pfizer Inc. said Tuesday that a new patent on one of its top drugs, anti-inflammatory painkiller Celebrex, extends its U.S. patent protection by 18 months, potentially bringing the company a few billion dollars ...
Medications
Mar 05, 2013 |
not rated yet |
0
Antiviral lipid earns patent: Lipids in lung can inhibit RSV and influenza infections
Dennis Voelker, PhD, professor of medicine at National Jewish Health, has been awarded a U.S. patent (#8,367,643) for various lipids and related compounds that can inhibit inflammation and infection in the lungs, especially ...
Medical research
Mar 05, 2013 |
4 / 5 (1) |
0
India rejects Bayer plea against cheap cancer drug (Update)
India's patent appeals office has rejected Bayer AG's plea to stop the production of a cheaper generic version of a patented cancer drug in a ruling that health groups say is an important precedent for getting ...
Medications
Mar 05, 2013 |
5 / 5 (4) |
3
Bayer vows to fight for patent on anti-cancer drug in India
German pharmaceuticals giant Bayer, maker of Aspirin, vowed Monday to fight a ruling by the patent authorities in India allowing a local company to produce and sell a generic copy of its anti-cancer drug Nexavar.
Medications
Mar 04, 2013 |
not rated yet |
0
Modified protein could become first effective treatment for vitiligo
Loyola University Chicago Stritch School of Medicine researchers have developed a genetically modified protein that dramatically reverses the skin disorder vitiligo in mice, and has similar effects on immune ...
Medical research
Feb 27, 2013 |
5 / 5 (2) |
0
|
Immune intervention reduces beta-cell death in type 1 diabetes
(HealthDay)—Patients recently diagnosed with type 1 diabetes have greater death of pancreatic β-cells compared with patients with long-standing diabetes, which can be reduced by treatment with teplizumab, ...
Diabetes
Feb 26, 2013 |
not rated yet |
0
Gene therapy may activate stem cells in heart failure patients
(HealthDay)—Delivery of an SDF-1 encoding plasmid (JVS-100) acts a homing signal for stem cells and improves clinical status in patients with symptomatic heart failure due to ischemic cardiomyopathy (IsCM), ...
Cardiology
Feb 22, 2013 |
not rated yet |
0
